Skip to content

Artivion AORT Change in AP

Change in AP at other companies

Edwards Lifesciences logo
Edwards LifesciencesEW
-$347.1M-236%
LeMaitre Vascular logo
LeMaitre VascularLMAT
-$2.34M+55.5%
Medtronic logo
MedtronicMDT
$123M-66.4%
ITG
Integer HoldingsITGR
$9.44M-7.5%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$4.49M+0.9%
Boston Scientific logo
Boston ScientificBSX
-$512M-33.0%

Other financials

Income statement

See full
Revenue$116.3M+17.5%
Gross profit$75.4M+18.7%
Operating income$5.8M+170%
Net income$1.4M+381%
EPS (diluted)$0.03+400%

Balance sheet

See full
Cash & equivalents$55.8M+47.9%
Total debt$258.2M-28.8%
Total equity$450.5M+53.1%
Total assets$883.2M+11.6%

Cash flow

See full
Operating cash flow$1.2M+107%
CapEx$8.0M+120%
Free cash flow-$6.8M+66.7%

Valuation

See full
Market cap$1.07B-22.7%
Enterprise value$1.27B-25.5%
P/E91.5×
P/S2.3×-1.2×

Profitability

See full
Gross margin64.6%+0.6pp
Operating margin8.2%+4.1pp
Net margin2.5%+1.5pp
FCF margin-0.1%-2.5pp

Returns & leverage

See full
Return on equity3.1%+1.8pp
Debt / equity0.6×-0.7×
Current ratio3.9×-1.7×

Where this comes from

Reported directly by Artivion in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artivion's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artivion's change in AP?
Artivion (AORT) reported change in AP of -$8.7M in Q1 2026.
How has Artivion's change in AP changed year-over-year?
Artivion's change in AP increased by 45.8% year-over-year, from -$16.05M to -$8.7M.
What is the long-term trend for Artivion's change in AP?
Over 2 years (2021 to 2025), Artivion's change in AP has grown at a 7.4% compound annual growth rate (CAGR), from -$1.89M to $2.18M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.